deoxyglucose has been researched along with Hematologic Malignancies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baik, KY; Choi, EH; Choi, TG; Kaushik, N; Kaushik, NK; Kim, CH; Lee, SJ; Uhm, HS | 1 |
| Li, X; Liu, X; Nie, C; Tan, S; Yuan, Z; Zhang, Y; Zhao, X | 1 |
2 other study(ies) available for deoxyglucose and Hematologic Malignancies
| Article | Year |
|---|---|
Non-thermal plasma with 2-deoxy-D-glucose synergistically induces cell death by targeting glycolysis in blood cancer cells.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Caspases; Cell Line; Cell Line, Tumor; Cell Survival; Cells, Cultured; Deoxyglucose; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; Gene Expression; Glycolysis; Hematologic Neoplasms; Humans; Mice; Plasma Gases; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; U937 Cells | 2015 |
Mcl-1 expression and JNK activation induces a threshold for apoptosis in Bcl-xL-overexpressing hematopoietic cells.
Topics: Antimetabolites; Antineoplastic Agents; Apoptosis; bcl-X Protein; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Deoxyglucose; Drug Synergism; Enzyme Activation; Hematologic Neoplasms; HL-60 Cells; Humans; Mitogen-Activated Protein Kinase 8; Myeloid Cell Leukemia Sequence 1 Protein; Phosphorylation; RNA Interference; Sulfonamides | 2017 |